Sign in
CompletedNo phase

The Safety of Pharmacopuncture on Musculoskeletal Patients

Key facts

Who runs it
Jaseng Medical Foundation
Where
South Korea7 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
1,000 people enrolled
Started
27 Apr 2022
Ended
3 Feb 2025
Type of study
Observational
Treatments tested
  • Pharmacopuncture
Record updated
4 September 2025

Who can take part

Age
19 years to 69 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • Inpatients with diagnosed spinal joint disease
  • Patients who received pharmacopuncture treatment during hospitalization
  • Patients who are 19 years of age or older and less than 70 years old
  • Patients who agreed to participate in the clinical study and voluntarily given written informed consent

Who cannot take part

  • Patients with difficulty or refusal to give sign written informed consent
  • Patients for whom the researchers judge participation in the clinical study to be difficult

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the safety of pharmacopuncture by observing any adverse events that may occur after pharmacopuncture treatment in with spinal joint disease hospitalized patients at 7 Korean medicine hospitals and analyzing blood test results.

Treatments tested

  • Pharmacopuncture

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Safety Assessment of Pharmacopuncture on Musculoskeletal Patients: a Multi-center, Registry
Record updated
4 September 2025